Delivery Order 75D30123D18250-75D30124F00002

Award Date 9/27/24
Potential Completion Date 9/26/27
Potential Value $742K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
6
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This delivery order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, a non-profit healthcare provider and research organization doing business as Kaiser Permanente. The contract is part of the CDC's Clinical Immunization Safety Assessment (CISA) program and has a ceiling value of $682,236. The order supports COVID-19 pediatric research at Kaiser Permanente, which has a long history of conducting evidence-based clinical research and...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $748,171 delivery order contract to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for PEDIATRIC COVID VACCINATION services. This contract is part of the CDC's Clinical Immunization Safety Assessment (CISA) program, a $86 million indefinite delivery vehicle that supports epidemiological and clinical research to evaluate vaccine safety. The contract has no set-aside designation, reflecting Kaiser Permanente's...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Kaiser Foundation Hospitals, doing business as Kaiser Permanente. The contract is a delivery order under the Clinical Immunization Safety Assessment (CISA) master indefinite delivery indefinite quantity (IDIQ) contract. The contract has a potential value of $370,216.00 and does not have a set-aside designation. Kaiser Foundation Hospitals, through its Kaiser Foundation...
This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. The $239,339 award is for the 2023 Clinical Immunization Safety Assessment (CISA) Base IDIQ, an indefinite delivery/indefinite quantity contract that supports epidemiological and clinical research to evaluate vaccine safety. The...
The Centers for Disease Control and Prevention (CDC) awarded a $11,470,897.31 firm fixed price contract to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. The contract, titled "CDC CFA EPID STUDIES", is not set aside for any special business designation. The contract supports epidemiology studies and investigations, leveraging Kaiser Permanente's access to large-scale electronic medical record data covering...
This is a $5,716,219.63 delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente. The contract supports the Vaccine Safety Datalink (VSD) program, a long-standing collaboration between the CDC and integrated healthcare systems to conduct surveillance on vaccine safety and effectiveness. This award is part of a larger indefinite delivery vehicle (IDV) contract...
This is a $646,694.92 firm fixed-price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. The contract is for the Vaccine Safety Datalink (VSD) project, a collaborative effort between the CDC and integrated healthcare systems to conduct post-licensure vaccine safety monitoring and evaluation. The award has no set-aside designation,...
This is a purchase order award by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, a non-profit healthcare provider and research organization doing business as Kaiser Permanente. The $116,746 firm fixed-price contract, awarded on September 30, 2015, is for unspecified products or services with a completion date of December 31, 2016. The award is not set aside for any particular type of business. Kaiser Permanente is an established federal contractor that...
This is a $150,000 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. The contract is for the UAC Ratification for FY 21 BAA Topic 9-KPSC, which does not have a set-aside designation. Kaiser Permanente is a major contractor for the CDC, holding several indefinite delivery vehicles (IDVs) to support ongoing federal...
This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. The contract is part of the Vaccine Safety Datalink (VSD) program, which supports ongoing vaccine safety monitoring and epidemiological research. The contract is valued at $29,702,854.60 and has an ultimate completion date of September 27, 2027. Kaiser Permanente has...
  • 75D30123D18250
    Indefinite Delivery Contract
  • 75D30123D18250-75D30124F00002
    Delivery Order

This is a $741,949.00 Delivery Order contract awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for the CISA RSV INFANTS STUDY (CONTRIBUTING SITE). The contract is not designated as a set-aside.

Kaiser Permanente is a large, non-profit healthcare provider and research organization that supports various federal public health initiatives through clinical research, data analysis, and implementation of evidence-based interventions. This contract is associated with the CDC's Clinical Immunization Safety Assessment (CISA) program, which conducts epidemiological and clinical research to evaluate vaccine safety. Kaiser Permanente has significant experience working with the CDC and other federal agencies through indefinite delivery vehicles like the CISA program and the Vaccine Safety Datalink program.

Generated 9/22/24, 12:47 AM